Junjie Teng Kai Zhou Dongxiao Lv Changshun Wu Hong Feng
10.3389/fphar.2022.714408
Front Pharmacol
2022 May 23;13:714408.
erbb2 mutation pten mutation adenocarcinoma cell lung carcinoma afatinib immunotherapy
CC BY
https://pubmed.ncbi.nlm.nih.gov/35677433/
Case Reports
PMC9168362
35677433
Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma
2022